Share

April 20, 2021; 96 (16) Article

Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D

Adam de Havenon, Alen Delic, Sarah Dehoney, Presley Whetman, Nazanin Sheibani, Brian Callaghan, John Ney, Gregory J. Esper, Brandon Magliocco, Kavita V. Nair
First published March 10, 2021, DOI: https://doi.org/10.1212/WNL.0000000000011712
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
109

Share

Article Information

vol. 96 no. 16 e2132-e2137
DOI: 
https://doi.org/10.1212/WNL.0000000000011712
PubMed: 
33692164
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 3, 2020
  • Accepted in final form January 28, 2021
  • First Published March 10, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Adam de Havenon, MD,
    2. Alen Delic, BS,
    3. Sarah Dehoney, PharmD,
    4. Presley Whetman, BS,
    5. Nazanin Sheibani, MD,
    6. Brian Callaghan, MD, MS,
    7. John Ney, MD, MPH,
    8. Gregory J. Esper, MD, MBA,
    9. Brandon Magliocco, MS and
    10. Kavita V. Nair, PhD
    Scientific Advisory Boards:

    1. Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Commercial or non profit entityAmerican Academy of Neurology

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Bristol Meyers SquibbNovartisGenentech

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis, Genentech

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Adam de Havenon, MD,
  2. Alen Delic, BS,
  3. Sarah Dehoney, PharmD,
    4. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) AMAG Pharmaceuticals, 2) Regeneron Pharmaceuticals

    Research Support, Government Entities:

    1. 1) NIH/NINDS, K23NS105924, Primary Investigator, 2019-2024

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) American Heart Association, Award Number 17SDG33670114, 2017-2020

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Presley Whetman, BS,
    5. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Nazanin Sheibani, MD,
    6. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Brian Callaghan, MD, MS,
    7. Scientific Advisory Boards:

    1. Consultant and scientific advisory board member on a PCORI grant

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) American Academy of Neurology, travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant and scientific advisory board member on a PCORI grant, consultant for DynaMed

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH 1R01DK115687, PI, 5 year awardVA CSRD Merit CX001504, PI, 4 year award

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. American Academy of NeurologyJuvenile Diabetes Research Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Consultant for medical legal cases and Division of Injury Compensation Program

  7. John Ney, MD, MPH,
    8. Scientific Advisory Boards:

    1. Scientific Merit Review Board (SMRB), HSR1 Section, VA

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Dr. Ney has received an honorarium from the AAN for speaking at the National Meeting.

    Editorial Boards:

    1. Editorial Board, Neurology: Clinical Practice

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1)Ceribell, Inc.2)JEM Research Institute3)SpecialtyCare,Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Gregory J. Esper, MD, MBA,
    9. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. I serve on the scientific advisory board of NeuroOne, Inc.I serve on the Healthcare Leadership Advisory Panel for Pfizer, Inc

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NeuroOne, Inc, 2017

    Legal Proceedings:

    1. Mitchell Law Group, expert witness for defendant, 2019Bradley Arant Boult Cummings LLP, expert witness for defendant, 2019Arnold, Welch, Todaro, and Foliano, Expert witness for defendant, 2020

  9. Brandon Magliocco, MS and
    10. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. I am an employee at the American Academy of Neurology. I conduct a wide range of research for the health policy division of the organization.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Kavita V. Nair, PhD
  1. From the University of Utah (A.d.H., A.D., S.D., P.W., N.S.), Salt Lake City; University of Michigan (B.C.), Ann Arbor; Boston University (J.N.), MA; Emory University (G.J.E.), Atlanta, GA; American Academy of Neurology (B.M.), Minneapolis, MN; and University of Colorado (K.V.N.), Denver.
  1. Correspondence
    Dr. de Havenon adam.dehavenon{at}hsc.utah.edu
View Full Text

Article usage

Article usage: March 2021 to March 2023

AbstractFullPdfSource
Mar 20211725048Highwire
Apr 20214661713Highwire
May 2021278159Highwire
Jun 202122446Highwire
Jul 202114612Highwire
Aug 20218533Highwire
Sep 202110575Highwire
Oct 202116953Highwire
Nov 202117044Highwire
Dec 20217911Highwire
Jan 202212621Highwire
Feb 202214510Highwire
Mar 202212201Highwire
Apr 20229002Highwire
May 202213013Highwire
Jun 20226510Highwire
Jul 20225612Highwire
Aug 20225012Highwire
Sep 20226100Highwire
Oct 20224711Highwire
Nov 20225820Highwire
Dec 20227720Highwire
Jan 20235613Highwire
Feb 20236900Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles